MMorgan Stanley LLam Research · LRCX

Morgan Stanley Lowers Lam Research Price Target to $367

Jul 30, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$367
Previous
$404
Implied upside
+45%

Morgan Stanley analyst Shane Brett lowered the price target on Lam Research (NASDAQ: LRCX) to $367 (from $404) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Previous notes from Morgan Stanley on Lam Research

Morgan Stanley Buy Raises targetJul 6, 2026 $404from $331 Morgan Stanley Buy Raises targetMay 18, 2026 $331from $293

Other Lam Research notes

UBSBuy Lowers target · Sep 1, 2026 $425from $435 MizuhoBuy Lowers target · Aug 25, 2026 $365from $370 BernsteinBuy Reiterate · Aug 10, 2026 from $360 B RileyBuy Reiterate · Jul 30, 2026 from $385 Wells FargoBuy Reiterate · Jul 30, 2026 from $450

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.